相关实验视频

Updated: Jul 11, 2025

Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol

Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol

Published on: March 25, 2020

尤基尼因改善了HepG2细胞和Caco-2细胞中的胆固醇代谢

Yuyang Ye¹, Asahi Takeuchi¹, Yuya Kawaguchi¹

¹Department of Applied Life Science, Faculty of Applied Biological Sciences, Gifu University, Gifu, Japan.

Bioscience, biotechnology, and biochemistry

|November 12, 2023

概括

发现eugeniin通过降低细胞内胆固醇水平来改善胆固醇代谢. 这种化合物对低密度脂蛋白受体 (LDLR) 进行上调,并对HMG-CoA减少酶进行下调,从而提供了潜在的治疗方法.

科学领域:

生物化学生物化学
分子生物学分子生物学
药理学药理学是指药理学的学科.

背景情况:

胆固醇代谢对细胞功能和整体健康至关重要.
胆固醇平衡的失调与各种疾病有关.
尤基尼因降低胆固醇的影响在很大程度上仍未被探索.

研究的目的:

为了研究尤基尼因对胆固醇代谢的影响.
阐明eugeniin对胆固醇的影响背后的分子机制.
评估eugeniin在人类细胞培养 (HepG2和Caco-2) 中的潜力.

主要方法:

用5μm欧基尼因对HepG2和Caco-2细胞进行治疗.
测量细胞内胆固醇的水平.
对关键胆固醇代谢调节者的蛋白质和mRNA表达的分析,包括LDLR和HMG-CoA减少酶.

主要成果:

尤基尼因在两种细胞类型中显著降低了细胞内胆固醇水平.
尤基尼因增加了低密度脂蛋白受体 (LDLR) 蛋白质和mRNA水平.
在特定的细胞类型和时间点中,尤基尼因降低了3-基-3-甲基-氨酸-共酶A减少酶 (HMG-CoA减少酶) 蛋白质和mRNA水平,并增加了ATP结合盒载体1 (ABCA1).

结论:

欧基尼因在人类细胞培养中显示出改善胆固醇代谢的作用.
这些机制包括调节LDLR,HMG-CoA减少酶和ABCA1.1.
欧吉尼因为控制胆固醇水平提供了一种新的治疗候选药物.

关键词:

在Caco-2细胞中.在HepG2细胞中.这就是为什么LDL,LDL是LDL.胆固醇胆固醇胆固醇是一种尤金尼因在他的

更多相关视频

Cholesterol Efflux Assay

Cholesterol Efflux Assay

Published on: March 6, 2012

Using Caco-2 Cells to Study Lipid Transport by the Intestine

Using Caco-2 Cells to Study Lipid Transport by the Intestine

Published on: August 20, 2015

相关概念视频

Cell Specific Gene Expression

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...